{
    "2018-12-05": [
        [
            {
                "time": "2018-06-15",
                "original_text": "Gilead's (GILD) Harvoni and Descovy Get Approval in China",
                "features": {
                    "keywords": [
                        "Harvoni",
                        "Descovy",
                        "approval",
                        "China"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-04",
                "original_text": "AbbVie halts late-stage trial for lung cancer drug Rova-T",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Rova-T",
                        "halted",
                        "trial"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-20",
                "original_text": "Why Oregon can now afford to treat more people with hepatitis C",
                "features": {
                    "keywords": [
                        "Oregon",
                        "hepatitis C",
                        "treatment",
                        "afford"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-11-12",
                "original_text": "Wall Street Is Souring on These 7 Stocks to Sell",
                "features": {
                    "keywords": [
                        "Wall Street",
                        "souring",
                        "stocks",
                        "sell"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-04",
                "original_text": "Phase 3 Trial of Rova-T as Second-line Therapy for Advanced Small-Cell Lung Cancer (TAHOE STUDY) Halted",
                "features": {
                    "keywords": [
                        "Phase 3",
                        "Rova-T",
                        "halted",
                        "trial"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-12-05",
                "original_text": "7 Dividend Aristocrats to Buy for 2019",
                "features": {
                    "keywords": [
                        "Dividend Aristocrats",
                        "buy",
                        "2019"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-10",
                "original_text": "J&J's Blood Cancer Drugs Succeed in Label Expansion Studies",
                "features": {
                    "keywords": [
                        "J&J",
                        "Blood Cancer",
                        "Drugs",
                        "Succeed",
                        "Label Expansion"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-15",
                "original_text": "Timely Ten- Top Values from IQ Trends",
                "features": {
                    "keywords": [
                        "Timely Ten",
                        "Top Values",
                        "IQ Trends"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}